• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. GEL MARK ULTRA MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. GEL MARK ULTRA MARKER Back to Search Results
Catalog Number GMUEC10GSS
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
It was reported that during a stereotactic breast biopsy procedure, a brest tissue marker was implanted.Images taken after marker placement which demonstrated migration of the marker.The breast was compressed prior to marker deployment.No patient injury was reported.
 
Manufacturer Narrative
After further clinical review of this event with bard's medical department, this event was reassessed and determined to be mdr reportable as a malfunction pursuant to 21 cfr part 803.A manufacturing review was conducted and the reported lot met all release criteria.The marker was not returned for evaluation; however, two cds of images were returned and reviewed.It is unknown whether the marker is placed at the intended site or if it had migrated whether the marker is placed at the intended site or if it had migrated, as no comparison images were provided.Based on the images provided, marker migration cannot be confirmed.Based on the available information, the complaint investigation is inconclusive and the definiitve root cause is unknown.It is unknown if patient and/or procedural issues contributed to the reported event.The current gel mark ultra marker instructions for use (ifu) provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.A-d: the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL MARK ULTRA MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
tempe AZ
Manufacturer (Section G)
INFUS MEDICAL (THAILAND)
700 moo 4, bangpoo industrial estate
samutprakarn province 1028 0
TH   10280
Manufacturer Contact
linda morocho
1625 west 3rd st.
tempe, AZ 85281
4808949515
MDR Report Key4909739
MDR Text Key15563935
Report Number2020394-2015-00960
Device Sequence Number1
Product Code FZP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K011402
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/22/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2013
Device Catalogue NumberGMUEC10GSS
Device Lot NumberVT12H0937
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/10/2015
Initial Date FDA Received06/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-